MGMucahit Gelmis

Mucahit Gelmis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mucahit Gelmis has a total of 124 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Does Cryptorchidism Influence Oncologic Outcomes in Testicular Germ Cell Tumors? A SEER Population-based Study

    by Oguzhan Yildiz, Sami Sekkeli, Mucahit Gelmis

    Our objective was to investigate whether cryptorchidism independently influenced cancer-specific survival (CSS) and overall survival in patients with testi

  • Open Access

    Does Illness Perception Influence Treatment Outcomes in Erectile Dysfunction? an Observational Study on Depressive Symptoms and Short-Term Treatment Response

    by Nazım Furkan Günay, Caglar Dizdaroglu, Mücahit Gelmiş, Feyzi Sinan Erdal, Faruk Özgör

    Objective: To investigate the relationship between illness perceptions, depressive symptoms, and erectile function (EF) in men with erectile dysfunction (ED) and to evaluate longitudinal changes following treatment.Materials and Methods: Patients with ED (IIEF-5 ≤21) were enrolled at a tertiary urology outpatient clinic between June and October 2025. Participants completed the International Index of Erectile Function-5 (IIEF-5), Patient Health Questionnaire-9 (PHQ-9), and Brief Illness Perception Questionnaire (B-IPQ) at baseline and at 1 and 3 months. All patients received lifestyle counseling and phosphodiesterase type-5 inhibitor therapy. Associations were analyzed using correlation and multivariable linear regression analyses.Results: A total of 120 patients completed follow-up. More negative illness perceptions were significantly associated with higher depressive symptom severity and worse ED severity (p < 0.05). B-IPQ scores increased progressively across categories of both depressive symptoms and ED severity. Multivariable analysis showed that education level, IIEF-5 score, and PHQ-9 score were independently associated with illness perception scores (all p

  • Open Access

    Her Yönüyle Üretra Darlığı

    by Abdulmuttalip Şimşek, Enes Yavuz, Sedat Çakmak, Buğra Çetin, Süleyman Şahin, Melih Yetemen, Burhan Coşkun, Metin Savun, Merve Şam Özdemir, Musab Ümeyir Karakanlı, et al.

  • Survival Outcomes and Prognostic Factors of Small Cell Carcinoma of the Kidney and Upper Urinary Tract: A SEER Database Analysis

    by Yasin Aktaş, Mücahit Gelmiş

    Objective: Small cell carcinomas of the kidney (SCCK) and the upper urinary tract (SCC UUT) are exceedingly rare and aggressive malignancies. This study aimed to compare survival outcomes of these two conditions using a large population-based database.Materials and Methods: Data from the Surveillance, Epidemiology, and End Results (SEER) database (2000–2022) were analysed. Patients with histologically confirmed SCCK (n = 41) and SCC UUT (n = 54) were included. Clinicopathological variables and treatment modalities were evaluated. Cancer-specific survival (CSS) was estimated using the Kaplan–Meier method and Cox proportional hazards models were employed to identify independent prognostic factors.Results: The study cohort consisted of 95 patients. Patients with SCCK exhibited significantly higher rates of distant metastasis than the UUT group (58.5% vs. 40.7%, p = 0.029). The median CSS was 9 months for the UUT group and 6 months for the kidney group (p = 0.068). Multivariate analysis in the kidney group identified surgical intervention (HR: 0.18, p

  • Sarcomatoid Carcinoma of the Prostate With Both Chondrosarcomatous and Osteosarcomatous Differentiation Following Androgen Deprivation Therapy: A Case Report and Diagnostic Considerations

    by Pelin Akbas, Sibel Bektas, Mucahit Gelmis, Ferhat Berker

    Background: Sarcomatoid carcinoma of the prostate is a rare and aggressive biphasic malignancy, typically arising in the setting of prior prostatic adenocarcinoma. Prominent heterologous differentiation may obscure its epithelial origin and lead to diagnostic confusion with primary mesenchymal tumors. Case presentation: We report an 80-year-old man with a history of metastatic prostate adenocarcinoma treated with androgen deprivation therapy, who presented with acute urinary obstruction and low prostate-specific antigen levels. Transurethral resection revealed a highly heterogeneous tumor composed of extensive cartilaginous and high-grade sarcomatoid components, including both chondrosarcomatous and osteosarcomatous differentiation. Despite thorough histopathological examination, no epithelial component was identified. Prior pathology confirmed adenocarcinoma up to 9 months earlier, with evidence of sarcomatoid transformation emerging in recent specimens. Immunohistochemistry supported mesenchymal differentiation. Based on clinicopathological correlation, a diagnosis of sarcomatoid carcinoma of the prostate with heterologous differentiation was established. Conclusion: This report highlights a significant diagnostic pitfall in which sarcomatoid carcinoma may mimic primary sarcoma when the sarcomatoid component predominates and epithelial elements are absent. It also underscores the potential role of androgen deprivation therapy in tumor dedifferentiation and the limitations of PSA in monitoring disease progression. Awareness of this entity is essential for accurate diagnosis and appropriate clinical management.

  • Global Research Trends And Knowledge Structure In Urethroplasty: A Bibliometric Analysis of The Literature From 2000 To 2024

    by Mücahit Gelmiş, Ali Ayten, Nazım Furkan Günay, Hakan Ceylan, Kanan Maharramov, Enver Özdemir

    Objective: To evaluate the global scientific output, collaboration patterns, influential contributors, core publication sources, and thematic trends in urethroplasty research through a comprehensive bibliometric analysis of the literature published between 2000 and 2024.Materials and Methods: This descriptive bibliometric study used the Web of Science Core Collection database. English-language articles and reviews published in the Science Citation Index Expanded between January 1, 2000, and December 31, 2024, were included. Publication and citation data, authors, countries, institutions, journals, and keywords were extracted. Analyses were performed using bibliometrix in R and VOSviewer to assess publication trends, collaboration networks, source patterns, keyword co-occurrence, and thematic structure. Bradford’s law was applied to identify core journals.Results: A total of 3661 publications from 489 sources were analyzed. The annual growth rate was 5.47%, the average citation per document was 16.42, and the mean document age was 9.98 years. Guido Barbagli was the most productive author, while the United States led in both publication output and citation count. China and India also showed high research productivity. Urology and Journal of Urology were the most productive journals. Collaboration analyses revealed prominent author- and country-level research clusters. Keyword and thematic analyses identified urethroplasty, urethral stricture, and hypospadias as core topics, with graft use, reconstructive techniques, outcomes, and recurrence emerging as major research themes.Conclusion: Urethroplasty research is concentrated around a limited number of influential authors, institutions, countries, and core journals, while continuing to expand in thematic scope and collaborative structure.

  • Impact of pT1a–pT1b Substaging on Recurrence and Progression in High-Grade T1 Bladder Cancer

    by Mücahit Gelmiş, Ali Ayten, Mehmet Özalevli, Hakan Ceylan, Kanan Maharramov, Burak Arslan, Sibel Bektaş

    Objective: To evaluate the prognostic impact of pT1a–pT1b substaging on recurrence and progression in patients with high-grade T1 bladder cancer and to determine whether substaging serves as an independent predictor when assessed alongside established clinical and pathological risk factors.Materials and Methods: This retrospective, single-center cohort study included patients diagnosed with high-grade pT1 urothelial carcinoma who underwent TURBT between January 2017 and March 2025. Cases with ≥pT2 disease, other malignancies, BCG contraindications, treatment non-compliance, incomplete follow-up, or trigonal tumors with unreliable muscularis mucosa assessment were excluded. Demographic, clinical, pathological, and follow-up data were extracted from institutional records. Recurrence and progression were defined according to standard criteria. Substaging was performed by experienced uropathologists. Survival outcomes were analyzed using the Kaplan–Meier method, and independent predictors were identified by multivariate Cox regression.Results: Of 152 patients, 110 (72.4%) were classified as pT1a and 42 (27.6%) as pT1b. CIS and tumor size ≥3 cm were significantly more frequent in pT1b cases. In multivariate analysis, CIS and tumor size ≥3 cm were independent predictors of both recurrence and progression. Although pT1b substaging was associated with worse recurrence-free survival on Kaplan–Meier analysis, it was not an independent predictor of recurrence in the Cox model; however, it independently predicted progression (HR=3.38). Kaplan–Meier analyses also demonstrated significantly worse progression-free survival in the pT1b group.Conclusion: pT1 substaging, particularly the identification of pT1b disease, provides meaningful prognostic information for progression in high-grade T1 bladder cancer. Integrating substaging with key pathological factors such as CIS and tumor size may improve individualized risk stratification and support early risk-adapted treatment decisions.

  • Learning curves after position switch in PCNL: prone- vs. supine-trained surgeons

    by Mucahit Gelmis, Ali Ayten, Oguzhan Yildiz, Hakan Ceylan, Kanan Maharramov, Enver Ozdemir